# Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease

> **NCT00252122** · PHASE4 · TERMINATED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 3 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT00252122
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-06
- **Primary completion:** 2005-11
- **Final completion:** 2007-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Recruitment was very slow.
- **Last updated:** 2009-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00252122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00252122, "Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00252122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*